Top pharma CEO compensation in 2018

Top CEO compensations provided by pharmaceutical companies in 2018

Show detailed source information?
Register for free
Already a member?
Log in

Use Ask Statista Research Service

Release date

May 2019



Survey time period


Number of respondents

base: 200 life sciences companies

Supplementary notes

For the report, BioPharma Dive explicitly grouped firms in these 3 categories: Large cap biotech: Market capitalization greater than $10 billion. Mid-sized biotech: Market capitalization between $2 billion and $10 billion. Small biotech: Market capitalization between $500 million and $2 billion.

This statistic is for firms in all the categories.

CEO compensation includes base salary, cash bonuses and long-term stock and option awards, as described in annual proxy filings.

Citation formats
Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$149 USD / Month *
Professional Account
Full access

Business Solutions including all features.

* Prices do not include sales tax.

Other statistics that may interest you

Other statistics that may interest you Statistics on

About the industry


About the region


Selected statistics


Other regions


Related statistics


Further related statistics

Statista Accounts: Access All Statistics. Starting from $1,788 USD / Year
Learn more about how Statista can support your business.